Identifying the target NSCLC patient for maintenance therapy: An analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)†

C. Obasaju, L. Bowman, P. Wang, W. Shen, K. B. Winfree, E. N. Smyth, M. E. Boye, W. John, T. Brodowicz, C. P. Belani

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint Dive into the research topics of 'Identifying the target NSCLC patient for maintenance therapy: An analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN)†'. Together they form a unique fingerprint.

Medicine & Life Sciences